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1. Introduction 
Complex regional pain syndromes (CRPS) are pain syndromes characterized by pain out of 
proportion to an inciting injury, swelling, discoloration, stiffness, hyperhidrosis 
(sudomotor), temperature (vasomotor) and trophic changes. Also commonly seen are fine 
tremor and less often spasms involving upper and lower extremities. Dr. Silas Wier Mitchell 
described CRPS II, or causalgia, during the American Civil War. CRPS I was described 
about the end of the 19th century by Sudek (Sudek’s atrophy). Evans described reflex 
sympathetic dystrophy (RSD). Numerous other terms used to describe similar syndromes 
include algodystrophy and shoulder- hand syndrome. Bonica described 3 stages of RSD. 
Roberts described sympathetically maintained pain.  
2. Diagnostic criteria 
Specific inclusion criteria are needed for research studies but from a clinical perspective, 
many patients seem to have a constellation of signs and symptoms of CRPS without meeting 
strict criteria. The diagnosis is made by the process of exclusion. While avoiding over 
diagnosing and over treatment, the patients need to be treated.  
3. Prognosis 
The prognosis for CRPS is highly variable and to a large extent is influenced by the 
treatment. Functional restoration and involving the patient in ongoing range of motion 
and resistive exercises is helpful. Timely pain relief and interventional pain procedures, as 
well as psychological support, are important. Patients need to be followed closely and 
treatments adjusted accordingly. Timely and appropriate referral to experienced pain 
physicians that are able to offer multimodal therapies may prevent costly delays and 
complications.  
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4. Theories of mechanisms 
Multiple possible mechanisms exist for CRPS including psychological, inflammatory, 
vascular, neurogenic and combinations of several mechanisms. Debate regarding definitions 
of neuropathic pain has led to the notion that CRPS may not be neuropathic pain. 
Psychogenic pain could be construed as being “pain arising as a direct consequence of a 
lesion or disease affecting the somatosensory system” but few would think of it as 
neuropathic pain which should be treated with anticonvulsants. 
CRPS II is generally agreed to be caused by an injury to a peripheral nerve. CRPS 1 is caused 
by a lesion in or injury to a small nerve or multiple small nerves. It is difficult to accept that 
it is not neuropathic pain since it resembles CRPS II so closely. Denial of care based on 
psychological explanations is neither reasonable nor justifiable yet in rare instances pain can 
be of psychological origin. Commonly the onset of CRPS is 1- 3 months after the injury. 
5. History 
The diagnosis is made by process of exclusion following history of pain that is out of 
proportion to an injury or period of immobilization. Swelling, temperature asymmetry, 
stiffness, atrophy, hair, skin nail, bone changes. Tremor or spasms and asymmetry in sweat 
function are all potential signs. It is important to remember that many injuries are associated 
with pain, discoloration and swelling without being CRPS. Infection and other causes of 
inflammation are sometimes mistakenly thought to be CRPS. A number of patients have CRPS 
symptoms following stroke and classifying this as central pain or CRPS is problematic. 
6. Physical exam 
Observation of upper extremity guarding or antalgic gait for lower extremity is important. 
Range of motion of affected joints is particularly important as many patients develop 
permanent stiffness without analgesia for specific range of motion therapy. Discoloration or 
asymmetrical coloration, swelling, atrophy and allodynia are other physical findings. The 
allodynia may be tactile or cold induced. 
7. Diagnostic tests 
Bone scans, sweat tests and sympathetic blocks have been used but the diagnosis is a clinical 
one and can be made without confirmatory tests. Thermography has been used, but more 
commonly, the documentation of temperature differences is adequate. Early on in the 
evolution of the condition there may increased temperature and later reduction with the 
increased sympathetic activity. Three phase bone scan often show corresponding changes. 
Comparing contra lateral x-ray images can show osteopenia in the involved area. EMG 
usually does not change from the CRPS but may show nerve injury. 
8. Differential diagnosis 
While it important to be vigilant in diagnosing CRPS, as is important to avoid misdiagnosis 
and over- diagnosis. Many patients have “pain out of proportion”, swelling and 
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discoloration after injuries and will improve within a month with usual therapeutic 
interventions. 
Infection is always a concern after surgery or other penetrating trauma. Other causes of 
acute inflammation, swelling and discoloration need to be considered such as malignancy, 
deep venous thrombosis as well as peripheral nerve entrapment, peripheral neuropathy and 
other neuropathic pains. 
9. Stages 
3 stages of RSD have been described however it is unclear that staging has much value 
regarding decision making.  
10. Timing 
Much has been made about early sympathetic blocks and failure to diagnose early. There is 
no data to support “emergent” sympathetic blocks and some patients have a favorable 
natural history. 
11. Spreading 
Pain from CRPS can spread, in rare instances, proximally and contra- laterally. (Shah, Racz) 
Lower extremity pain can spread to upper extremities and vice versa. 
12. Bone loss 
Osteopenia and fractures can occur in severe cases and aquatic therapy is useful to 
rehabilitate these patients. 
13. Natural history 
The natural history of CRPS 1 is variable but in an interesting report, approximately 25% of 
patients that had Colles’ fractures developed signs of CRPS. (Atkins) Approximately 40% of 
these patients improved in 6 months. This suggests that mild cases may not require 
extensive treatment. Not treating the patients early can be problematic if the condition 
worsens. Appropriate examination and follow up is important where the disease can take a 
benign course. Patients obtain information on the Internet that is usually about catastrophic 
cases that needs to be dealt with by educating patients in an appropriate and caring manner 
where therapy is timely yet one can avoid catastrophizing based on inaccurate information. 
14. Dogma 
Much of “standard care” is not evidence based, but good outcome based. Additionally, it is 
based on physician experience and the outcome is superior in the hands of better-trained 
physicians. As new information becomes available, dogma can be weeded out and 
treatments based on randomized controlled trails can be incorporated into treatment 
guidelines.  
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15. Cases 
One lady had not worn high-heeled shoes for a long time and then wore a pair for  
several hours at an event. She developed classic signs and symptoms of RSD. She 
experienced profound analgesia with sympathetic blockade and the condition resolved 
completely. 
Another case was a woman who had a paper cut on her distal index finger on the job. She 
had classic signs and symptoms of CRPS, which resolved with a series of blocks. Both of 
these cases were challenged by insurance companies since the inciting injury was so 
minor but both patients were legitimate. The point is that physicians caring for these 
patients must be willing to serve as advocates for the patient even in an environment of 
cost containment. We have to be mindful of our “report cards” but not at the expense of a 
patient’s outcome.  
16. Overmedication pain syndrome (OPS) 
Approximately 20 years ago, a movement began to improve the quality of pain care for 
cancer patients worldwide. The WHO analgesic ladder was promoted for cancer pain and 
then it was applied for other types of pain. Many patients are now taking large doses of 
opioid for chronic pain. 
Overmedication pain syndrome is characterized by a chronic treatment program consisting 
of high doses of multiple analgesic medications without associated functional productivity 
and psychological coping ability.  
Opioids are the most important class of drugs in pain management; however, it is clear that 
they are two edged swords and overmedication with opioids and other drugs classes have 
become a problem. Abuse may not be the largest problem. Lack of efficacy, unintended 
overdose, diversion, development of drug dependence, habituation and resistance to 
recovery and other unintended consequences may be more common.  
Opioid induced hyperalgesia is a real clinical phenomenon and may be a subtle barrier to 
analgesia in many patients. Pain that is only incrementally responsive to opioid is also 
common. 
Pseudo-addiction is defined in behavioral terms which are similar to addiction but related to 
pain and not addiction. The problem is that there are not good means to differentiate 
behaviors between the setting of pain and the setting of addiction. 
Some have reported a lack of data to support doses of opioid over 200 mg/day of morphine 
equivalents. Also, there are no long term randomized controlled trials of opioid versus 
placebo. Additionally, fracture rates have been reported to be increased in patients on doses 
above 100 mg/day. (Sullivan) Overdose rates have been reported to increase above 50 
mg/day. (Dunn) Drug interactions with other medications, reported and unreported to the 
treating physician, have been causes of fatalities. 
Urine drug testing, opioid contracts and extensive documentation guidelines fail to help 
answer the clinical question: is the dose just too high? 
Patients who are taking opioids chronically should be considered for an evaluation for a 
lack of meaningful efficacy, fall and fracture risk and overdose risk. An interdisciplinary 
evaluation may be a way to accomplish these objectives. Patients who are clearly doing well 
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may be less likely to accept dose reductions. Patients who are working or similarly 
productive and are without signs of poor coping and physical disability may need to 
continue taking the effective dosages. On the other hand, patients, who have been on stable 
doses for a long time may need age related dose reductions.  
Washington State has new guidelines limiting the dose of opioid to 120 mg/day of 
morphine equivalents. Patients, who require doses above this level, are guided to seek a 
pain management consultation. The purpose and intervention of a medical pain 
management consultation is unclear. The practitioner doing the evaluation needs to have 
additional training and qualification as well as be informed and knowledgeable in treatment 
options in addition to opioid management.  
JCAHO, Press Gainey and other organizations have changed the environment with respect 
to patient rights regarding pain. In the past, if a patient wasn’t happy with their opioid dose, 
their recourse was limited. Now, patient satisfaction is used as a factor to determine 
healthcare provider’s compensation. The implication is that patients can pressure providers 
to prescribe more opioid, which is dangerous for patients and providers.  
Regulators have become more active due to the increased rate of diversion and its 
consequences. However, the accidental overdose rate increase is even more concerning.  
Most drugs have dose limits. For example, antibiotics and drugs for hypertension are 
increased to upper limits but there are limits. Perhaps it is time to limit doses of opioids 
regardless of pain severity for patients with non palliative care pain syndromes and find 
another way to treat the patient. 
Other drugs classes that are problematic include benzodiazepines, muscle relaxers, sleeping 
pills and even anticonvulsants and antidepressants. Benzodiazepines are not prominent in 
the pain literature as analgesics. Baclofen and tizanidine are probably the first line muscle 
relaxers of choice. Hypnotic drugs are used too often for chronic sleep disturbances without 
sleep hygiene treatment or other medications which are better for long term use. 
Anticonvulsant use for chronic pain has exploded as opioids have. Antidepressants, even 
those not associated with analgesia, are prescribed for pain. 
The costs of these drugs are significant and usually of incremental benefit. Most patients 
with chronic pain go without an interdisciplinary evaluation and many who receive an 
evaluation do not complete treatment with cognitive behavioral therapy, education and 
conditioning physical therapy. Treatment goals are frequently not established and some 
patients just go through the motions and are considered as a treatment failure. There is very 
little evidence for the multidisciplinary and physical therapy based treatments specifically 
for CRPS. Reimbursement has suffered for these kinds of therapies. 
The cognitive effects and psychological effects of chronic opioid treatment are not well 
known. 
Testosterone levels in males are known to decrease with chronic opioid administration.  
It is proposed that patients with chronic pain have a short term trial of low dose opioid  
to access functional improvement before a treatment plan is finalized. Blinding patients to 
their drug and dose may be very helpful but has its critics on ethical and regulatory 
grounds. 
Patients who are on doses above 50 mg/ day of morphine equivalents need to have access to 
interdisciplinary pain and addictionology evaluations and treatment if needed. Treatment 
goals should include dose reduction to below 200mg/day of morphine equivalents for those 
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taking more than that. Intermediate term treatment goals for patients taking less than  
200 mg/day should strive for less than 100 mg/day and patients taking less than  
100 mg/day, 50 mg/day.  
There is no data to support this approach but there was no data 20 years ago to support 
using the WHO analgesic ladder for headaches, fibromyalgia, back pain or any other 
condition. Data for limited doses of opioid for arthritis and neuropathic pain exists and 
prescribing for opioid responsive pain should not be overly scrutinized by regulators. Never 
the less, diversion, addiction, opioid induced hyperalgesia and other adverse events 
associated with opioids need to be avoided more effectively before the first prescription is 
written.  
Many patients in drug treatment programs were initially treated with opioid for perfectly 
legitimate pain. The patient and the doctor may not be the biggest problems. The biggest 
problem may be the drug and the dosage. 
17. Treatment guideline history 
In 1994, the International Association for the Study of Pain (IASP) revised the terminology 
from RSD and causalgia to CRPS type I and II. 15 years ago we proposed an analgesic 
ladder for CRPS /RSD which included 3 steps. (Racz) Since then, well-respected groups 
have advanced other guidelines. (Van Eijs) (Stanton-Hicks)  
Our initial proposal was: 
Step 1. TENS, opioids, topicals, Tricyclic antidepressants, supportive psychotherapy, 
vocational rehabilitation, patient education, physical therapy and occupational 
therapy  
Step 2. Regional or sympathetic block, evaluation and treatment of the emotional 
component of pain, IV regional block, peripheral block-infusion, carbamazepine, 
baclofen, clonidine, corticosteroid, NSAID, mexiletine, other drug trials 
Step 3. Sympathectomy/sympatholysis, peripheral nerve decompression, lysis, continuous 
local anesthetic infusion epidural and or regional for five to seven days, Spinal 
Cord Stimulation (SCS), Peripheral Nerve Stimulation (PNS), intrathecal/epidural 
analgesia. 
At that time, little data existed to guide treatment and the initial analgesic ladder was based 
on opinion. Since that time, additional data has been produced leading to modifications to 
the analgesic ladder. This is categorically not intended to estabish a standard of care since 
data to do such is inadequate. Rather, our intention is to share our beliefs in hopes of 
helping patients with this disorder. 
18. New principles and information 
Our current analgesic ladder promotes several concepts: 
1. Interdisciplinary pain treatment is recommended rather than multidisciplinary care 
which tends to be fragmented. Interdisciplinary treatment specifically provides 
coordinated medical care, education, cognitive behavioral therapy for pain, physical 
therapy and outcome documentation by the interdisciplinary team. Patients who 
receive care at different clinics for each component of care by a group of providers who 
do not meet on a weekly basis nor document comprehensive outcomes are not receiving 
interdisciplinary pain management.  
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2. Interdisciplinary care is not isolated from medical pain management. Analgesic 
treatments are necessary to provide pain relief and allow functional restoration.  
3. The course of an individual patient is highly variable and adjustments to the treatment 
plan should be made in a highly flexible manner.  
4. Limiting opioid doses to below 200mg/day morphine equivalents 
5. Numerous randomized controlled trials have been performed since our initial analgesic 
ladder was proposed and these findings are incorporated.  
6. However if there is treatment failure and functional restoration failure the patient needs 
to be referred to centers or individuals with recognized experience to be specialists in 
the field. 
Sympathetic blocks have been recommended early on in the management of the disorder 
but little data exists to support this practice. Only recently has any data from a randomized 
controlled trial been published to demonstrate efficacy of sympathetic blockade. (Meier) 
Spinal cord stimulation has been shown to produce significant analgesia even after 5 years 
of treatment. (Klemer) Cortical stimulation has been shown to have some benefit. (Velasco) 
Deep brain stimulation has been shown to be ineffective. Vitamin C has been studied by 
multiple investigators for the prevention of CRPS and has some effect. (Besse) Intravenous 
magnesium has been reported to be effective in an initial study. (Collins) Clodronate has 
been shown to be partially effective. (Varenna) Mirror therapy has been reported to have 
benefit in stroke patients with CRPS. (Cacchio) Multicenter comparison of spinal cord  
stimualtion and peripheral nerve stimulation showed  that PNS is more effective than SCS 
but the best outcome was where both modalities were utilized. ( Calvillo) 
Intravenous regional anesthesia with the addtion of vasodilators such as phentolamine, 
reserpine and bretylium allow manipulation of hands without post  procedure edema  and 
speed up functional restoration without  the pain associated with physical therapy. 
(Heavner, Calvillo, Racz) 
An evidenced based review endorses bisphosphonates (alendronate, pamidronate, 
clodronate), corticosteroid, gabapentin, physiotherapy and psychotherapy/relaxation 
techniques as treatments. (Baron) Additionally intrathecal baclofen for associated dystonia 
and spinal cord stimulation for refractory caes are recommended. Topical DMSO and 
sympathetic blocks are not strongly recommended. Intravenous regional blocks with 
guanethidine are not recommended as specific treatment (Van Eijs)  
19. Treatments to avoid 
Amputation is less common nowadays because it was rarely effective and usually resulted 
in a phantom pain plus different pain of greater severity  
IV regional with guanethidine has been shown to be ineffective in several studies as sole 
agent. 
Deep brain stimulation has been shown to be ineffective. 
High dose opioid should be avoided if possible due to possible opioid induced 
hyperalgesia, addiction, diversion risk and over-dosage. 
20. Proposed treatment 
Step 1.  
Screening for substance abuse, affective disorders and disability 
Education 
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Physical therapy 
Occupational therapy 
Vocational rehabilitation 
Topical lidocaine for allodynia 
Tricyclic antidepressants 
Gabapentin 
Tramadol 
Opioid doses limited to less than 200mg morphine equivalents per day and below 
50mg/day if possible 
Corticosteroid 
Step 2.  
Interdisciplinary pain evaluation including psychological testing (MMPI-RF) and treatment 
(cognitive behavioral therapy, group psycho educational therapy and psychotropic 
medication management, addictionology, physical and occupational therapy, in a 
coordinated goal directed, outcome documenting rehabilitation program) 
Sympathetic block 
IV Regional block 
Peripheral block 
Other drug trials 
Step 3.  
Spinal cord stimulation 
Sympathectomy/sympatholysis 
Peripheral nerve stimulation 
Peripheral nerve decompression/lysis 
Intrathecal/epidural analgesia 
21. Interdisciplinary care 
Interdisciplinary pain management is a term that is poorly understood. It is best reserved to 
describe a team of healthcare professionals led by a physician and including a psychologist 
and physical therapist at a minimum. A care team of multiple physicians from different 
specialties is not an interdisciplinary team for pain management nor is a psychologically 
based treatment program in isolation from medical pain management. Cognitive behavioral 
therapy, education and functional rehabilitation must be provided in an interdisciplinary 
pain care model in addition to medical pain management therapies. Case management, 
psychiatry, outcome database management, nursing, vocational rehabilitation, occupational 
therapy, medical direction and program direction and administrative support are key 
disciplines to include in a mature pain program. Nutrition, chaplaincy and other medical 
specialties are needed for tertiary programs. 
22. Conclusion 
Complex regional pain syndrome is a challenging pain problem that frequently requires a 
comprehensive interdisciplinary assessment and treatment plan. Until a mechanism is 
discovered and a specific treatment for the syndrome is developed, an interdisciplinary 
approach, including pharmacologic and interventional pain management in a step wise 
fashion, will likely remain as the best route to follow.  
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